Invivo Analytics
Invivo Analytics is a private, all-remote SaaS company that provides AI-powered preclinical imaging analysis software for pharmaceutical companies and academic researchers, combining cloud-native radiomics with proprietary hardware modules and patented automated quantification.
- Company typePrivate
- Founded2012
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Invivo Analytics does
Invivo Analytics, Inc. is a private, all-remote SaaS company headquartered in New York that builds AI-powered preclinical imaging analysis software for pharmaceutical, biotech, and academic research buyers. Founded in 2012 by Neal Paragas (Columbia University, biology) and Alexander Klose (Freie University, physics), the company originated from work at Columbia's preclinical imaging facility and is supported by NIH, the National Cancer Institute, and Convergence Design Lab. Its core platform, InVivoAX, is a cloud-native radiomics engine that automates multi-modal image quantification, organ segmentation, and biodistribution analysis to replace manual, operator-dependent workflows in drug discovery and disease modeling. Company-published claims include 100x faster analysis, 3x more data per study, and 5x lower per-subject cost relative to traditional contract research organizations.
The product portfolio combines proprietary hardware with software modules. The Body Conforming Animal Mold (BCAM) and Organ Probability Map (OPM) underpin every workflow, providing consistent spatial registration and operator-independent organ segmentation. Plug-in modules include InvivoPLOT for 3D bioluminescence tomography, InVivoGRID for high-throughput bioluminescence imaging, and InvivoPET for PET/CT analysis. The company has issued patents on core optical tomography and image reconstruction technology (June 2023) and is developing InVivoSCAN, a modular bioluminescence imaging platform funded by NIH SBIR awards in 2025. Integrations span major preclinical imaging OEMs, including PerkinElmer IVIS Spectrum, Spectral Instruments Lago, Analytic Jena UVP iBox Scientia, Siemens, Mediso, and Sophie PET/CT systems.
Revenue is generated through SaaS subscriptions to InVivoAX plus hardware sales of BCAM molds and plug-in modules, with quote-based enterprise sales and annual billing cadence. Pricing is not publicly disclosed. The two primary customer segments are pharmaceutical and biotech companies conducting drug discovery and academic and research institutions running preclinical studies. The company has funded operations primarily through NIH SBIR grants rather than priced venture capital. With 1–10 employees distributed across the United States and active engineering hiring, Invivo Analytics remains in early-stage commercialization with patent-protected technology, advisor Christopher Contag (founder of Xenogen/IVIS), and growing product breadth.
Invivo Analytics firmographics
Firmographics- Name
- Invivo Analytics
- Legal name
- InVivo Analytics, Inc.
- Website
- https://invivo.ax
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Invivo Analytics is a private, all-remote SaaS company that provides AI-powered preclinical imaging analysis software for pharmaceutical companies and academic researchers, combining cloud-native radiomics with proprietary hardware modules and patented automated quantification.
- Ownership category
- akta.pro rank
Invivo Analytics industry classification
Industry- Product category
- Preclinical Imaging Software
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Scientific Research and Development Services (5417)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
Keywords
Where Invivo Analytics is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Invivo Analytics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Software-as-a-Service (SaaS) Subscriptions: Cloud-based SaaS platform sold as subscription using different plugin modules. Users pay for access to the InVivoAX platform for image analysis and data management.
- Hardware Sales (BCAM, Plug-in Modules): Sale of proprietary hardware including Body Conforming Animal Molds (BCAM), InVivoPLOT mirror gantry, InVivoGRID shuttle systems, and PET/CT adapter modules.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | SaaS platform with plugin modules for different imaging modalities |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Invivo Analytics product offering
Product offeringCore offering
InVivo Analytics operates InVivoAX, a cloud-native AI-powered SaaS platform for preclinical molecular imaging data analysis. The platform automates quantification of bioluminescence tomography (BLT), bioluminescence imaging (BLI), and PET/CT data using proprietary Body Conforming Animal Mold (BCAM) hardware and Organ Probability Map (OPM) software, eliminating operator bias and manual data processing while increasing throughput and reproducibility for drug discovery researchers.
Product overview
Invivo Analytics offers InVivoAX, a cloud-based AI-powered SaaS platform for preclinical molecular imaging data analysis, complemented by specialized plug-in modules. The product portfolio includes InvivoPLOT (quantitative 3D bioluminescence tomography), InVivoGRID (high-throughput bioluminescence imaging), and InVivoPET (automated PET/CT analysis), all utilizing proprietary Body Conforming Animal Mold (BCAM) and Organ Probability Map (OPM) technologies for consistent, operator-independent analysis. The company is developing InVivoSCAN, a modular bioluminescence imaging platform. The platform claims 100x faster analysis, 3x more data, and 5x cost savings per subject compared to CROs.
Differentiator
Problem solved
Functional benefit
Brands
- InVivoAX: Cloud-based SaaS image analysis platform for preclinical molecular imaging data analysis
- InvivoPLOT
- InVivoGRID
- InVivoPET
- InVivoSCAN
Products and services
- InVivoAX AI-powered cloud-based SaaS platform for preclinical molecular imaging data analysis. Automates image data processing across bioluminescence tomography, bioluminescence imaging, and PET/CT modalities to accelerate drug discovery, eliminating operator bias and manual data processing while increasing data throughput and reproducibility. Accessible to unlimited users for enterprise deployments.
- InvivoPLOT (BLT Plug-in Module) Quantitative 3D bioluminescence tomography (BLT) plugin module consisting of a multi-view mirror gantry and light-transport reconstruction algorithm for automated 3D tomographic image reconstruction. Performs automated quantification using BCAM and OPM and is compatible with Spectral Instruments Imaging Lago, PerkinElmer IVIS Spectrum, and Analytic Jena UVP iBox Scientia imaging systems.
- InVivoGRID (BLI Plug-in Module) High-throughput bioluminescence imaging (BLI) plugin module with flippable animal shuttle and integrated anesthesia providing a reproducible geometric framework for small animal imaging experiments. BCAM sizes fit 14–40 gram animals. Compatible with PerkinElmer IVIS Spectrum and Spectral Instruments Imaging Lago systems.
- InVivoPET (PET/CT Plug-in Module) Cloud-based data analysis tool for PET and SPECT imaging of small animals enabling automatic biodistribution and SUV calculation, DICOM viewing, tumor volume calculation, and 3D visualization. Features BCAM shuttle adapters for Sophie, Mediso, and Siemens PET/CT systems.
Quantifiable outcome
- 100x faster analysis compared to traditional methods
- +2 more outcomes
Companies that use Invivo Analytics
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Invivo Analytics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability7 records
Feature7 records
Invivo Analytics partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Invivo Analytics competitors and assessment
Company assessmentBroad incumbents
- Revvity (formerly PerkinElmer Life Sciences): Revvity owns the IVIS line of in vivo optical imaging systems that InvivoPLOT and InVivoGRID integrate with, and ships its own bundled preclinical imaging software. It is the dominant incumbent in the optical preclinical imaging category where Invivo Analytics competes as a third-party analytics overlay.
- Molecular Devices (Danaher): Molecular Devices provides preclinical and cell-based imaging instruments with associated analysis software for drug discovery workflows. Comparable as a bundled instrument-plus-software incumbent serving similar pharma/biotech R&D customers.
- Bruker BioSpin (Preclinical Imaging): Bruker offers preclinical MRI, PET, and optical imaging systems with bundled analysis software serving pharma and academic researchers. It represents the broad incumbent that ships instrument-and-software solutions competing against InvivoAX's third-party analytics layer.
Direct peers
- Mediso Medical Imaging Systems: Mediso manufactures small-animal PET/CT scanners (e.g., nanoScan) explicitly listed as compatible with the InvivoPET shuttle. Mediso is a direct peer in preclinical PET hardware, with bundled software competing against InvivoAX.
- Spectral Instruments Imaging: Spectral Instruments Imaging manufactures the Lago small-animal optical imaging system, which InvivoPLOT and InVivoGRID are explicitly designed to integrate with. Both companies serve the same preclinical bioluminescence/fluorescence imaging workflow.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Invivo Analytics social profiles
Digital presenceInvivo Analytics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Invivo Analytics leadership team
Management profileNumber of profiles
Profiles5 records
Invivo Analytics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Invivo Analytics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Invivo Analytics
What does Invivo Analytics do?
InVivo Analytics operates InVivoAX, a cloud-native AI-powered SaaS platform for preclinical molecular imaging data analysis. The platform automates quantification of bioluminescence tomography (BLT), bioluminescence imaging (BLI), and PET/CT data using proprietary Body Conforming Animal Mold (BCAM) hardware and Organ Probability Map (OPM) software, eliminating operator bias and manual data processing while increasing throughput and reproducibility for drug discovery researchers.
Is Invivo Analytics a public or private company?
Invivo Analytics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Invivo Analytics founded?
Invivo Analytics was founded in 2012. It employs 1 to 10 people.
Where is Invivo Analytics based?
Invivo Analytics is headquartered in New York, United States, in the North America region.
How does Invivo Analytics make money?
Two revenue lines are on record. Software-as-a-Service (SaaS) Subscriptions are the primary driver. The others are hardware Sales (BCAM, Plug-in Modules).
Who are Invivo Analytics's main competitors?
Broad incumbents on record are Revvity (formerly PerkinElmer Life Sciences), Molecular Devices (Danaher) and Bruker BioSpin (Preclinical Imaging). Direct peers are Mediso Medical Imaging Systems and Spectral Instruments Imaging.
Does Invivo Analytics have an API?
No public API is recorded for Invivo Analytics.
What industry is Invivo Analytics in?
Invivo Analytics's product category is Preclinical Imaging Software. Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334516 and its SIC code is 3841.